Gu Jin Attends 2026 AstraZeneca China National Distributor Conference with Genertec Meheco and CQP

On February 4, Gu Jin, Vice President and Member of the Leading Party Members Group of Genertec Group, led a delegation including Yang Guang (Chairman and Secretary of the Party Committee of Genertec Meheco), Yuan Quan (Chairman and Secretary of the Party Committee of C.Q. Pharmaceutical Holding (CQP)), and Li Shaohong (Senior Vice President and Member of the Party Committee) to attend the 2026 AstraZeneca China National Distributor Conference in Shanghai. The conference, themed Collaborative Innovation for a New Chapter, showcased the strong synergy and integrated development of Genertec Group's pharmaceutical segment. The conference was attended by AstraZeneca China's senior executives, including General Manager Lin Xiao, Oncology Business General Manager Guan Dongmei, Vice President of Market Access Huang Bin, Vice President and Head of Rare Diseases Hu Yiqing, and Assistant Vice President of Wide Area Market Access and Commercial Operations Li Shupeng. The comprehensive agenda featured business reviews, the unveiling of strategies, R&D roadmap presentations, industry forum discussions, and award ceremonies. Central to the discussions were cutting-edge topics such as innovative commercial insurance payment models and AI applications. These discussions highlighted the participating companies' deep commitment to the Chinese market and their strategic focus on extending innovations to a global scale.